03-17-2021, 12:19 AM
(03-16-2021, 11:43 PM)LP link Wrote:You can't ignore the timeline [member=57]ElwoodBlues1[/member].Relevance is CSL need the business and Scotty needs a cheap vaccine to give to the plebs. The CSL share price has dropped about $50 and you got to keep the shareholders happy...
How could the health workers at MBB's mother's work get AstraZeneca before we actually had any in the country? The first health workers only started getting AstraZeneca last week, the assertion the doctors only get Pfizer is rubbish!
MBB was posing the very same question a couple of weeks back, days before AstraZeneca even arrived in the country. The assertion/conspiracy is all built on social media rumours that are baseless. The irony being if you want to be worried about a new technology, it's the mRNA vaccines you should be more worried about!
I notice you quote a lot of business / corporate investment related COVID-19 facts, I gather this comes from some corporate rag, for example the blood plasma business stalled comments you made above. What is the relevance of this downturn in altering vaccine production decisions? Aren't all those plasma business in the same boat because there are less blood donations, so there is no inherent bias across the board!
My main concern isn't funding CSL, it's why we are preferentially funding CSL for expanding old technologies, as I've mentioned before if mRNA proves safe and efficacious that older adenovirus technology could quickly become redundant. My associate asked this question to a top CSL executive at a recent sporting event, his response was they Feds will fund a second round of upgrades to include the new mRNA technologies anyway, upgrading capacity of the existing technologies was a faster to market situation! However, long term if the adenovirus route offers vaccines in a pill or nasal spray the old technology could win out, so I can understand why they aren't throwing the baby out with the bath water.
CSL also had a failed union with the Uni of Queensland to create their own vaccine and were/are very keen to stay in vaccine market.
Of course the locally produced variety hasn't been approved by the TGA yet..


